Molson Coors (TSX:TPX.B) Could Strike It Rich in 2020 With New Cannabis Drinks

The partnership between Molson Coors Canada Inc. (TSX:TPX.B) and cannabis producer Hexo Corp. (TSX:HEXO)(NYSE:HEXO) could send shares soaring.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is one of the best-known beverage companies in Canada. Its roots stretch back to 1786, when John Molson founded the Molson Brewery, the oldest brewery in North America as well as Canada’s second-oldest company.

Today, Molson has expanded globally, with dozens of brands and millions of annual customers. Despite its long and storied history, 2020 could be a year of firsts.

In 2018, Molson partnered with cannabis producer Hexo Corp. (TSX:HEXO)(NYSE:HEXO) to co-create cannabis-infused drinks.

“Canada is breaking new ground in the cannabis sector and, as one of the country’s leading beverage companies, Molson Coors Canada has a unique opportunity to participate in this exciting and rapidly expanding consumer segment,” Molson’s management team said.

“While we remain a beer business at our core, we are excited to create a separate new venture with a trusted partner that will be a market leader in offering Canadian consumers new experiences with quality, reliable and consistent non-alcoholic, cannabis-infused beverages.”

The partnership got off to a slow start as many consumables categories weren’t legalized in Canada until October of this year.

It appears that there was a great deal of progress behind the scenes, however, as the company recently revealed that its new products will hit the shelves as early as this month, with scaling efforts expected in early 2020.

The market isn’t ready for it, but both Molson and HEXO shares could explode if early traction is achieved. How likely is that? Let’s find out.

Ignorance isn’t bliss

Thus far, most cannabis investors have ignored non-smokable cannabis form factors. Analysts and even cannabis companies themselves have invested very little in the space. That’s a mistake.

Looking at the numbers, categories like cannabis-infused beverages could ultimately exceed the market size for traditional form factors like dry flowers and concentrates.

How big could cannabis-infused beverages get? As with any early-stage product, no one is certain, but we can glean some helpful clues from similar markets, namely the alcohol industry.

Alcoholic beverage sales in Canada is set to reach $51 billion this year. That’s an incredible figure that works out to more than $1,500 per Canadian adult. Long-term annual growth of 2.6% is expected — roughly triple overall population growth.

Canadians simply love their alcohol. Could this demand translate to cannabis drinks? Absolutely.

Given that traditional cannabis turned into a multi-billion market in a handful of years, it won’t be surprising to see cannabis beverages follow a similar path.

Today, sales of cannabis-infused beverages in Canada is roughly zero. At just 10% the size of the alcohol market, this could be a $5 billion opportunity.

When it comes to tapping this nascent market, Molson and Hexo lead the pack, allowing their partnership to establish early adoption and brand loyalty, not to mention building growing data set on user preferences and buying behaviour.

Molson generated $2 billion in sales this year in Canada. There’s a chance that its cannabis business could add $1 billion to that figure over the next few years alone.

HEXO, meanwhile, is expected to generate less than $200 million in sales next year. Its Molson partnership alone has the potential to double that estimate.

All of this depends on whether consumers will consume cannabis drinks in a similar manner to alcoholic drinks. If even a small fraction of alcohol consumers take the plunge, Molson and HEXO will be minting millions.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »